• Home
  • Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors.

Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors.

Author List
Naing A, Algazi AP, Falchook GS, Creelan BC, Powderly J, Rosen S, Barve M, Mettu NB, Triozzi PL, Hamm J, Zhou G, Walker C, Dong Z, Patel MR
Publication
Cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/366109903
Publication Year
2022
PubMed ID
36309837
Publication Title
Naing A, Algazi AP, Falchook GS, Creelan BC, Powderly J, Rosen S, Barve M, Mettu NB, Triozzi PL, Hamm J, Zhou G, Walker C, Dong Z, Patel MR. Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors. Cancer. 2023 01 01; 129(1):71-81.